Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Not Confirmed
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
Global ChemShowGlobal ChemShow
Industry Trade Show
Not Confirmed
19-20 December, 2025
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Digital content

12 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251112497891/en/Alto-Neuroscience-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Business-Highlights

28 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251028146760/en/Alto-Neuroscience-to-Participate-in-Upcoming-Investor-Conferences

20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251020503608/en/Alto-Neuroscience-Announces-%2450-Million-Private-Placement-Financing

20 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251020895285/en/Alto-Neuroscience-Announces-Plans-to-Accelerate-Development-of-ALTO-207-in-Treatment-Resistant-Depression-Following-Successful-Outcome-from-Recent-FDA-Meeting

03 Oct 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251003096029/en/Alto-Neuroscience-Receives-FDA-Fast-Track-Designation-for-ALTO-101-for-the-Treatment-of-Cognitive-Impairment-Associated-with-Schizophrenia

09 Sep 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250909814928/en/Alto-Neuroscience-Announces-Robust-Replication-of-EEG-Biomarker-to-Objectively-Identify-Patients-with-Cognitive-Impairment-in-Schizophrenia
ABOUT THIS PAGE